The cost effectiveness of LAA exclusion

Bahij Kreidieh, Moisés Rodríguez-Mañero, Sergio H. Ibarra-Cortez, Paul Schurmann, Miguel Valderrábano

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Left atrial appendage (LAA) exclusion strategies are increasingly utilized for stroke prevention in lieu of oral anticoagulants. Reductions in bleeding risk and long-term compliance issues bundled with comparable stroke prevention benefits have made these interventions increasingly attractive. Unfortunately, healthcare funding remains limited. Comparative cost economic analyses are therefore critical in optimizing resource allocation. In this review we seek to discourse the cost economics analysis of LAA exclusion over available therapeutic alternatives (warfarin and the new oral anticoagulants (NOACs)).

Original languageEnglish (US)
Pages (from-to)37-42
Number of pages6
JournalJournal of Atrial Fibrillation
Volume8
Issue number5
StatePublished - Feb 1 2016

Keywords

  • Cost effectiveness
  • Lariat
  • Left atrial appendage exclusion
  • Watchman

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'The cost effectiveness of LAA exclusion'. Together they form a unique fingerprint.

Cite this